Selective inhibition of purified human phosphodiesterase 4A expressed in yeast cell GL62 by ciclamilast, piclamilast, and rolipram

Acta Pharmacologica Sinica

Volumn 25, Issue 9, 2004, Pages 1171-1175

  Chen, Jun Chun ^a   Chen, Ji Qiang ^a   Xie, Qiang Min ^a   Zhu, Yi Liang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

3 ,5 cyclic nucleotide phosphodiesterase; 3 (cyclopentyloxy) N (3,5 dichloro 4 pyridyl) 4 methoxybenzamide; Ciclamilast; Phosphodiesterase inhibitors; Rolipram; Saccharomyces cerevisiae; Zaprinast

Indexed keywords

ACETYLSALICYLIC ACID; CICLAMILAST; INDOMETACIN; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PICLAMILAST; ROLIPRAM; UNCLASSIFIED DRUG; ZAPRINAST;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; YEAST CELL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ASPIRIN; BENZAMIDES; INDOMETHACIN; PHOSPHODIESTERASE INHIBITORS; PURINONES; PYRIDINES; ROLIPRAM; SACCHAROMYCES CEREVISIAE;

EID: 4544236707     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Soderling SH, Beavo JA. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 2000; 12: 174-9.
2. Yuasa K, Kanoh Y, Okumura K, Omori K. Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAP domains. Eur J Biochem 2001; 268: 168-78.
3. Souness JE, Aldous D, Sargent C. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 2000; 47: 127-62.
4. Essayan DM. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem Pharmacol 1999; 57: 965-73.
5. Huston E, Pooley L, Julien P, Scotland G, McPhee I, Sullivan M, et al. The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both paniculate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram. J Biol Chem 1996; 271: 31334-44.
6. Kovala T, Sanwal BD, Ball EH. Recombinant expression of a type IV, cAMP-specific phosphodiesterase: characterization and structure-function studies of deletion mutants. Biochemistry 1997; 36: 2968-76.
7. Wang K, Chen JQ, Chen Z, Chen JC. Inhibition of human phosphodiesterase 4A expressed in yeast cell GL62 by theophylline, rolipram, and acetamide-45. Acta Pharmacol Sin 2002; 23: 1013-7.
8. Glaser KB, Hulkower KI, Carlson RP. Therapeutic approaches to allergic and inflammatory diseases: fourth annual midwest meeting of the inflammation research association. Inflamm Res 1996; 45: 438-41.
9. Cherry JA, Davis RL. Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 1999; 407: 287-301.
10. Cho CH, Cho DH, Seo MR, Juhnn YS. Differential changes in the expression of cyclic nucleotide phosphodiesterase isoforms in rat brains by chronic treatment with electroconvulsive shock. Exp Mol Med 2000; 32: 110-4.
11. Muller T, Engels P, Fozard JR. Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends Pharmacol Sci 1996; 17: 294-8.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
13. Wilson M, Sullivan M, Brown N, Houslay MD. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast. Biochem J 1994; 304 (Pt 2): 407-15.
14. Burnouf C, Pruniaux MP. Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr Pharm Des 2002; 8: 1255-96.
15. Ji H, Xie QM, Chen JQ. Comparison of piclamilast with ciclamilast in bronchodilating and antiallergic effects. J Zhejiang Univ (Medl Sci) 2003; 32: 274-8.